DE3882725D1 - Verfahren zur trennung von boesartigen zellen aus einer klinischen probe. - Google Patents

Verfahren zur trennung von boesartigen zellen aus einer klinischen probe.

Info

Publication number
DE3882725D1
DE3882725D1 DE8888300969T DE3882725T DE3882725D1 DE 3882725 D1 DE3882725 D1 DE 3882725D1 DE 8888300969 T DE8888300969 T DE 8888300969T DE 3882725 T DE3882725 T DE 3882725T DE 3882725 D1 DE3882725 D1 DE 3882725D1
Authority
DE
Germany
Prior art keywords
fragments
cells
medium
tumor
serum
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8888300969T
Other languages
English (en)
Other versions
DE3882725T2 (de
Inventor
Boris M Rotman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ANALYTICAL BIOSYSTEMS CORP
Original Assignee
ANALYTICAL BIOSYSTEMS CORP
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ANALYTICAL BIOSYSTEMS CORP filed Critical ANALYTICAL BIOSYSTEMS CORP
Application granted granted Critical
Publication of DE3882725D1 publication Critical patent/DE3882725D1/de
Publication of DE3882725T2 publication Critical patent/DE3882725T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0693—Tumour cells; Cancer cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/24—Methods of sampling, or inoculating or spreading a sample; Methods of physically isolating an intact microorganisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/803—Physical recovery methods, e.g. chromatography, grinding
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/80—Fluorescent dyes, e.g. rhodamine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/813—Cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DE88300969T 1987-02-05 1988-02-05 Verfahren zur Trennung von bösartigen Zellen aus einer klinischen Probe. Expired - Fee Related DE3882725T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/011,219 US4937187A (en) 1983-02-04 1987-02-05 Methods for separating malignant cells from clinical specimens

Publications (2)

Publication Number Publication Date
DE3882725D1 true DE3882725D1 (de) 1993-09-09
DE3882725T2 DE3882725T2 (de) 1994-02-17

Family

ID=21749375

Family Applications (1)

Application Number Title Priority Date Filing Date
DE88300969T Expired - Fee Related DE3882725T2 (de) 1987-02-05 1988-02-05 Verfahren zur Trennung von bösartigen Zellen aus einer klinischen Probe.

Country Status (6)

Country Link
US (1) US4937187A (de)
EP (1) EP0277837B1 (de)
JP (1) JPS63263081A (de)
AT (1) ATE92534T1 (de)
CA (1) CA1293216C (de)
DE (1) DE3882725T2 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5242806A (en) * 1990-05-07 1993-09-07 Baxter Diagnostics Inc. Method for conducting the cytotoxicity assays on tumor cells
US5962317A (en) * 1995-10-18 1999-10-05 The Johns Hopkins University School Of Medicine Dosage modeling system
US6287848B1 (en) 1995-10-18 2001-09-11 Johns Hopkins University Dosage modeling system
US20040072722A1 (en) 2002-10-10 2004-04-15 Kornblith Paul L. Methods for assessing efficacy of chemotherapeutic agents
US6416967B2 (en) * 1996-07-12 2002-07-09 Precision Therapeutics, Inc. Method of using multicellular particulates to analyze malignant or hyperproliferative tissue
US5728541A (en) 1996-07-12 1998-03-17 Precision Therapeutics, Inc. Method for preparing cell cultures from biologial specimens for chemotherapeutic and other assays
US20040023375A1 (en) * 2002-07-30 2004-02-05 Precision Therapeutics, Inc. Method for preparing cell cultures from biological specimens for chemotherapeutic and other assays
US6316215B1 (en) 1999-12-27 2001-11-13 Edwin L. Adair Methods of cancer screening utilizing fluorescence detection techniques and selectable imager charge integration periods
FR2782730B1 (fr) * 1998-08-25 2002-05-17 Biocom Sa Procede de separation cellulaire pour l'isolation de cellules pathogeniques, notamment cancereuses rares, equipement et reactif pour la mise en oeuvre du procede et application du procede
US6750037B2 (en) 1999-12-27 2004-06-15 Edwin L. Adair Method of cancer screening primarily utilizing non-invasive cell collection, fluorescence detection techniques, and radio tracing detection techniques
US6984498B2 (en) 1999-12-27 2006-01-10 Adair Edwin L Method of cancer screening primarily utilizing non-invasive cell collection, fluorescence detection techniques, and radio tracing detection techniques
US6190877B1 (en) * 1999-12-27 2001-02-20 Edwin L. Adair Method of cancer screening primarily utilizing non-invasive cell collection and fluorescence detection techniques
CN1484709A (zh) 2000-09-09 2004-03-24 ŦԼ������ѧ�о������ 分离转移性癌细胞的方法与组合物,及其在检测癌转移性上的应用
US20040086888A1 (en) * 2001-10-18 2004-05-06 Kornblith Paul L Method for tandem genomic/proteomic analysis of proliferating cells
EP1374912B1 (de) 2002-06-21 2006-08-16 Edwin L. Adair Anwendung von Metalloporphyrinen zur Behandlung von Arteriosklerose
AU2006287175A1 (en) * 2005-09-01 2007-03-08 Precision Therapeutics, Inc. Chemo-sensitivity assays using tumor cells exhibiting persistent phenotypic characteristics
DE102012003700B3 (de) * 2012-02-28 2012-11-29 FLACOD GmbH Verfahren zur Trennung von Verbänden maligner Zellen und Verbänden aus Stromazellen einer Malignomgewebeprobe

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3073746A (en) * 1959-05-21 1963-01-15 Organon Process for culturing altered human secretory pituitary cells
US3586859A (en) * 1970-02-16 1971-06-22 Irwin J Katz Fluorescent cell viability counter
GB1376131A (en) * 1971-02-09 1974-12-04 Nat Res Dev Improvements in and relating to cell culture systems
US3821087A (en) * 1972-05-18 1974-06-28 Dedrick R Cell culture on semi-permeable tubular membranes
US3948732A (en) * 1973-05-31 1976-04-06 Instrumentation Laboratory, Inc. Cell culture assembly
US4201845A (en) * 1976-04-12 1980-05-06 Monsanto Company Cell culture reactor
US4184922A (en) * 1977-11-11 1980-01-22 The Government Of The United States Dual circuit, woven artificial capillary bundle for cell culture
US4220725A (en) * 1978-04-03 1980-09-02 United States Of America Capillary cell culture device
US4242459A (en) * 1978-11-02 1980-12-30 Chick William L Cell culture device
US4241187A (en) * 1979-03-27 1980-12-23 United States Of America Method and apparatus for cell and tissue culture
JPS5642584A (en) * 1979-09-18 1981-04-20 Asahi Chem Ind Co Ltd Cell cultivation method
US4308351A (en) * 1980-04-18 1981-12-29 Joseph Leighton System for growing tissue cultures
US4332893A (en) * 1980-06-13 1982-06-01 Rosenberg Ralph A Process for the production of an insulin-producing cell line of pancreatic beta cells
US4350768A (en) * 1980-09-19 1982-09-21 Bristol Myers Company Method for preparing single cell suspension
US4423145A (en) * 1981-05-07 1983-12-27 Stampfer Martha R Enhanced growth medium and method for culturing human mammary epithelial cells
CA1178183A (en) * 1981-05-14 1984-11-20 David J. Zahniser Disaggregation device for cell suspensions
US4537860A (en) * 1982-12-08 1985-08-27 Monsanto Company Static cell culture maintenance system
US4582787A (en) * 1982-12-30 1986-04-15 Frankel Jack W Method of testing a patient for a predisposition to lung cancer, certain other cancers, neurofibromatosis and certain other hereditary disorders
US4734372A (en) * 1983-02-04 1988-03-29 Brown University Research Foundation Cell culturing methods and apparatus
US4559299A (en) * 1983-02-04 1985-12-17 Brown University Research Foundation Inc. Cytotoxicity assays in cell culturing devices
US4554251A (en) * 1983-11-07 1985-11-19 The Ohio State University Research Foundation Process and medium for culturing ant venom gland cells

Also Published As

Publication number Publication date
CA1293216C (en) 1991-12-17
DE3882725T2 (de) 1994-02-17
EP0277837A3 (en) 1989-12-06
EP0277837A2 (de) 1988-08-10
US4937187A (en) 1990-06-26
EP0277837B1 (de) 1993-08-04
ATE92534T1 (de) 1993-08-15
JPS63263081A (ja) 1988-10-31

Similar Documents

Publication Publication Date Title
DE3882725D1 (de) Verfahren zur trennung von boesartigen zellen aus einer klinischen probe.
Salehinejad et al. Comparison of different methods for the isolation of mesenchymal stem cells from human umbilical cord Wharton’s jelly
Halldorsson et al. Poly (ADP-ribose) polymerase activity in nucleotide permeable cells
Zhang et al. Isolation and characterization of mesenchymal stem cells from whole human umbilical cord applying a single enzyme approach
JP2005517441A (ja) 臍帯血由来の間葉幹細胞・前駆細胞の分離培養方法及び間葉組織への分化誘導方法
DE60019111D1 (de) Verfahren zur zellseparation unter verwendung von immunorosetten
ATE162631T1 (de) Ein nichtinvasives verfahren zur trennung und zum nachweis von fetaler dna
ATE161041T1 (de) Verfahren zur hcv-züchtung in zell-linien aus b- oder t-lymphozyten
JP2009517079A (ja) Ｏｃｔ４発現能を有する臍帯血由来の多分化能性成体幹細胞及びその製造方法
Ryan et al. Effect of culture conditions on enzyme activities in cultivated human fibroblasts
CN111484972A (zh) 一种从儿童包皮培养获得具备多向分化潜能和免疫调节功能间充质干细胞的方法
ATE530657T1 (de) Verfahren zur herstellung von zellinien mit latentem immunschwächevirus
CN1293189C (zh) 一种从骨实质中分离间充质干/祖细胞的方法
ATE33269T1 (de) Methode zur vorbehandlung einer probe, zusammensetzung hierfuer und diese enthaltender testsatz fuer eine agglutinationsbestimmung.
CN111979177B (zh) 一种人胆管上皮细胞的制备方法及其培养基
NZ509451A (en) Assay for the presence or quantity of a hormone, lipid, nucleic acid or enzyme in a mammal to indicate the presence of non-fertilisable ova capable of in vitro maturation are present
CN113106058A (zh) 一种人脐带来源Muse细胞的筛选与鉴定方法
CN101418284A (zh) 分离纯化人羊水干细胞的方法
Sterling et al. Separation and quantitation of porphyrins employing an EDTA buffer system
McClay et al. Involvement of histocompatibility antigens in embryonic cell recognition events
FI871830A0 (fi) Immobilisering av celler som inte fastnar vid en baerare.
Blüthmann et al. Enzyme activity profiles in mouse teratocarcinomas: a quantitative ultramicroscale analysis
JPS5515746A (en) Preparation of l-alpha-glycerophosphoric acid oxidase
ATE313622T1 (de) Verfahren zur züchtung von haftenden tierischen zellen
ATE56751T1 (de) Verfahren zur trennung von tierischen zellen aus fluessiger kultur.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee